The Role of Robotics in Infectious Disease Crises

Gregory D. Hager, Vijay Kumar, Robin R. Murphy, Daniela Rus, Russell H. TaylorarXiv 2020 · arXiv

Abstract

The COVID-19 pandemic exposed critical vulnerabilities in healthcare and public safety systems worldwide. While software-based interventions were deployed rapidly, robotic systems—essential for physical tasks in "dull, dangerous, and dirty" environments—faced significant hurdles in adaptation and deployment. This paper synthesizes the findings of a workshop co-hosted by the National Academy of Engineering (NAE) and the Computing Community Consortium (CCC), identifying the research, regulatory, and infrastructure barriers that must be addressed to transform robotics into a "plug-and-play" resource for future infectious disease crises.

Introduction: The Preparedness Gap

During the height of the COVID-19 crisis, the need for physical automation became apparent. Robots could theoretically handle disinfection, logistics, and high-risk patient care, thereby preserving personal protective equipment (PPE) and reducing human exposure to pathogens. However, a "preparedness gap" emerged: unlike software, which can be updated and distributed almost instantaneously, robotic systems require long lead times for physical interaction reliability. Current systems are often too rigid, expensive, or complex for non-experts to operate under the high-stress conditions of a medical surge.

Methodology

This synthesis is based on a virtual workshop held in July 2020, which brought together over 40 experts, including roboticists, clinicians, emergency responders, and public health officials. The expert panel categorized the challenges facing the field into three primary domains:

  1. Capability Barriers: Fundamental limitations in autonomy, sensing, and fine motor skills.
  2. Mobilization Barriers: Difficulties in rapid manufacturing, system verification, and supply chain agility.
  3. Environment-Specific Barriers: Challenges unique to infectious settings, such as the requirement for constant chemical disinfection and the need for intuitive human-robot interaction (HRI).

Key Insights: Robots as "Physical Software"

A central theme of the workshop was the conceptualization of robots as "physical software." To be effective in a crisis, we cannot wait for the emergency to begin before developing specialized hardware. Instead, the report advocates for an "installed base" of adaptable robots already integrated into everyday use—such as in hospital logistics or routine cleaning. These systems can then be repurposed via software updates during a surge.

Furthermore, the evolution of telepresence is critical. While current robots often provide simple video-conferencing, the next generation must move toward "semi-autonomous mobile manipulation." This would enable clinicians to remotely perform physical tasks, such as adjusting a ventilator or managing IV lines, without entering a contaminated zone.

The Human Element and Trust

For robotics to succeed in clinical settings, they must be usable by "inexpert" users—overworked nurses and doctors who lack technical training in robotics. If a system adds even a marginal increase to a healthcare worker's cognitive load or daily schedule, it is likely to be rejected. Trust is built through reliability and ease of use; therefore, "just-in-time" training modules that can teach operation in minutes are essential.

Strategic Results and Regulatory Hurdles

The report analyzed 203 instances of robot use during the COVID-19 pandemic. Notably, only 13 of these instances involved "new missions." The vast majority were established roles, such as delivery or disinfection, that were simply scaled up. This suggests that the primary challenge is not inventing new tasks, but making existing capabilities robust and deployable.

The most significant non-technical hurdle identified was regulatory and financial. Hospitals are often hesitant to adopt expensive robotic systems without clear pathways for reimbursement from insurers or government agencies like FEMA. A National Strategy is required to harmonize these regulatory frameworks and provide incentives for everyday adoption.

Limitations and Future Directions

Despite the potential, several technical gaps remain:

  • The Dexterity Gap: Robots still struggle with the fine motor control needed for delicate medical procedures, such as swabbing or handling tubing.
  • The "Black Box" Problem: As robots increasingly rely on AI and machine learning, verifying their safety in unpredictable clinical environments becomes more difficult.
  • Self-Disinfection: Future research must focus on materials that are inherently self-disinfecting to prevent robots from becoming disease vectors themselves.

Conclusion

The transition of robotics from niche tools to essential pandemic infrastructure requires a coordinated National Strategy. By focusing on adaptable, everyday systems and addressing the regulatory bottlenecks of reimbursement, the robotics community can ensure that the next infectious disease crisis is met with a robust, physical response.

Summary updated

BibTeX
@misc{hager2020role,
  author = {Gregory D. Hager and Vijay Kumar and Robin R. Murphy and Daniela Rus and Russell H. Taylor},
  title = {{The Role of Robotics in Infectious Disease Crises}},
  year = {2020},
  eprint = {2010.09909},
  archivePrefix = {arXiv},
  url = {https://arxiv.org/abs/2010.09909},
}
Figure